Skip to main content
. 2016 Dec 9;8(6):859–874. doi: 10.1080/21505594.2016.1270494

Table 2.

Strains used in this study or tested in the colony immunoblot.

Blot Position Species, strain Capsule type Description or source Ref. or source
  Staphylococcus spp.      
A3 S. epidermidis RP62A NA Biofilm producing, methicillin-resistant strain 65
A4 S. haemolyticus JCSC 1435 NA Sequenced strain from a Japanese patient in Tokyo 66
A5 S. saprophyticus 15305 NA ATCC; genome sequenced uropathogenic isolate 67
A6 S. lugdunensis 45–6447 NA Bacteremia isolate from 2014 BWHa
  Staphylococcus aureus      
B1 Newman 5 Human isolate from 1952 68
B2 Mu50 5 Vancomycin-intermediate MRSA isolate; Japan 69
B3 COL 5 MRSA strain with SCCmecII 65
B4 502A 5 Strain adept at colonization 70
B5 NRS 382 5 USA100 MRSA NARSAb
B6 NRS 383 5 USA200 MRSA NARSA
B7 NRS 386 5 USA700 MRSA NARSA
C1 Lowenstein 5 Nabi serotype 5 reference strain 71
C2 Reynolds (CP5) 5 Prototype CP5+ strain 17
C3 Reynolds Δcap5H 5 Produces WT levels of O-deacetylated CP5 51
C4 Crimson 5313 5 Bacteremia isolate from 2012 BWH
C5 Crimson 18207 5 Bacteremia MRSA isolate from 2013 BWH
C6 29213 5 Antibiotic susceptibility testing reference strain ATCC
C7 ST22 #15 5 CA-MRSAc from 2010; Regensburg, Germany F. Hanses
D1 MN8 8 Menstrual toxic shock isolate 72
D2 ST80–16 8 CA-MRSA strain from 2010; Regensburg, FRG 73
D3 Wright 8 Nabi serotype 8 reference strain 71
D4 PS80 8 ATCC 27700 58
D5 Becker 8 Prototype CP8+ strain 74
D6 V8 8 Source of staphylococcal V8 protease 75
D7 HS-522 8 ST239 MRSA 76
E1 NRS 387 8 USA800 MRSA NARSA
E2 NRS 483 8 USA1000 MRSA NARSA
E3 NRS 484 8 USA1100 MRSA NARSA
E4 GFRY 8 Bacteremia isolate from 1997 BWH
E5 VP 8 Bacteremia isolate from 1995 41
E6 JP122 8 Bacteremia isolate from 1990 BWH
E7 JP136 8 Bacteremia isolate from 1990 BWH
F1 25923 8 Seattle 1945; antibiotic reference strain ATCC
F2 Reynolds (CP8) 8 Reynolds genetically modified to produce CP8 17
F3 UAMS-1 8 Genome sequenced musculoskeletal isolate 77
F4 2672 8 USA400; necrotizing pneumonia and sepsis isolate 32
F5 RF122 8 Genome sequenced bovine isolate 78
F6 Sanger 252 8 Epidemic MRSA clone 31
F7 MW2 8 Community acquired MRSA; USA400 79
G1 Sanger 476 CP- Community acquired MSSA; USA400 31
G2 8325–4 CP- NCTC; cured of three prophages 80
G3 LAC CP- Los Angeles clone; USA300 MRSA 81
G4 NRS 482 CP- USA300 MRSA NARSA
G5 NRS 691 CP- USA500 MRSA NARSA
G6 Cowan I CP- Isolate with high protein A expression 82
G7 Reynolds (CP-) CP- Reynolds acapsular mutant 17

Note.

a

BWH, Brigham and Women's Hospital, Boston, MA.

b

NARSA, Network on Antimicrobial Resistance in Staphylococcus aureus.

c

CA-MRSA, community-acquired methicillin resistant Staphylococcus aureus.